Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Medipharm Labs Corp (LABS.TO)

Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 30,304
  • Shares Outstanding, K 404,049
  • Annual Sales, $ 33,062 K
  • Annual Income, $ -13,083 K
  • 60-Month Beta 1.57
  • Price/Sales 0.82
  • Price/Cash Flow N/A
  • Price/Book 0.57
Trade LABS.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.04
  • Most Recent Earnings $-0.01 on N/A
  • Latest Earnings Date 05/20/24
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.01
  • Number of Estimates 2
  • High Estimate -0.01
  • Low Estimate -0.01
  • Prior Year -0.01
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0750 unch
on 04/23/24
0.1000 -25.00%
on 03/26/24
-0.0100 (-11.76%)
since 03/22/24
3-Month
0.0600 +25.00%
on 01/30/24
0.1000 -25.00%
on 03/26/24
+0.0100 (+15.38%)
since 01/23/24
52-Week
0.0550 +36.36%
on 07/26/23
0.1000 -25.00%
on 03/26/24
-0.0050 (-6.25%)
since 04/21/23

Most Recent Stories

More News
MediPharm Labs Provides Conference Call Recording Details

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0589 (+5.18%)
LABS.TO : 0.0750 (unch)
MediPharm Labs Reports Fourth Quarter and Full Year Results

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0589 (+5.18%)
LABS.TO : 0.0750 (unch)
Stocks in play: MediPharm Labs Corp.

Provides an update on German cannabis legalization. Germany's upper house, the Bundesrat (made up of ...

LABS.TO : 0.0750 (unch)
MediPharm Labs Provides Update on German Cannabis Legalization

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0589 (+5.18%)
LABS.TO : 0.0750 (unch)
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial Results

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0589 (+5.18%)
LABS.TO : 0.0750 (unch)
Stocks in play: MediPharm Labs Corp.

Announced receipt of GMP certification for their Barrie, Ontario facility from ANVISA, the governing ...

LABS.TO : 0.0750 (unch)
MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health Authority

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0589 (+5.18%)
LABS.TO : 0.0750 (unch)
Stocks in play: MediPharm Labs Corp.

Announced an update regarding its Board of Directors and employee stock issuance. Effective immediately ...

LABS.TO : 0.0750 (unch)
MediPharm Labs Provides Update on Board of Directors and Long Term Incentive Program

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0589 (+5.18%)
LABS.TO : 0.0750 (unch)
MediPharm Labs Reports Third Quarter Results

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0589 (+5.18%)
LABS.TO : 0.0750 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis flower, extracts, and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops,...

See More

Key Turning Points

3rd Resistance Point 0.0833
2nd Resistance Point 0.0817
1st Resistance Point 0.0783
Last Price 0.0750
1st Support Level 0.0733
2nd Support Level 0.0717
3rd Support Level 0.0683

See More

52-Week High 0.1000
Fibonacci 61.8% 0.0828
Fibonacci 50% 0.0775
Last Price 0.0750
Fibonacci 38.2% 0.0722
52-Week Low 0.0550

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar